Today: 20 March 2026
Subscribe
Browse Category

SHA:603986.SS 18 January 2026 - 26 January 2026

GigaDevice (603986) Class A stock: profit alert and insider sales set up Monday tradeGigaDeviceGigaDevice (603986) Class A stock: profit alert and insider sales set up Monday trade

GigaDevice (603986) Class A stock: profit alert and insider sales set up Monday tradeGigaDeviceGigaDevice (603986) Class A stock: profit alert and insider sales set up Monday trade

GigaDevice’s Shanghai A shares closed Friday at 297.25 yuan, down 1.4%, after executives sold 244,500 shares for 73.29 million yuan. The company forecasts 2025 net profit of 1.61 billion yuan, up 46%, and plans to allocate 500 million yuan to DRAM expansion. Shareholders will vote Feb. 11 on a US$221 million DRAM contract and KPMG’s appointment as auditor.
26 January 2026
·
GigaDevice Class A stock heads into Monday after 46% profit jump forecast and DRAM funding moves

GigaDevice Class A stock heads into Monday after 46% profit jump forecast and DRAM funding moves

GigaDevice Semiconductor’s Class A shares fell 1.4% to 297.25 yuan in Shanghai on Friday. The company projected 2025 net profit to rise 46% to 1.61 billion yuan, with revenue up 25%. Investors are watching funding moves ahead of a Feb. 11 shareholder vote on related-party spending and auditor appointments. GigaDevice plans to buy $221 million in DRAM products from ChangXin group in H1 2026.
25 January 2026
···
Giga Device Semiconductor Class A stock hits limit-up in Shanghai as memory-price bets build into Monday

Giga Device Semiconductor Class A stock hits limit-up in Shanghai as memory-price bets build into Monday

GigaDevice Semiconductor’s Shanghai shares surged 10% to 280.46 yuan Friday, hitting their daily limit on heavy volume. Hong Kong-listed shares jumped 16.7% to HK$272. Semiconductor stocks outperformed as memory prices climbed and traders looked ahead to the company’s March 31 earnings. Mainland markets remain closed until Monday.
18 January 2026
···

Stock Market Today

  • Kessler Topaz Meltzer & Check Files Securities Fraud Class Action Against Soleno Therapeutics
    March 20, 2026, 1:23 PM EDT. Kessler Topaz Meltzer & Check, LLP has filed a securities fraud class action lawsuit against Soleno Therapeutics, Inc. (NASDAQ: SLNO) concerning purchases of SLNO stock between March 26 and November 4, 2025. The lawsuit alleges that Soleno made materially false statements and omissions about safety concerns in its Phase 3 clinical trial for diazoxide choline extended-release tablets used to treat hyperphagia linked to Prader-Willi syndrome. The firm claims the company concealed issues relating to excess fluid retention in trial participants. Investors have until May 5, 2026, to seek lead plaintiff status. The complaint is pending in the U.S. District Court for the Northern District of California under case number 3:26-cv-01979. Investors who suffered losses are urged to contact the law firm for legal options at no cost.
Go toTop